Global Aquaculture Feed and Pharmaceuticals Market Research Report 2019 (Includes Business Impact of COVID-19)

                                          
"The ongoing Coronavirus (COVID-19) pandemic is re-shaping everything from global economies to product categories, pricing, and stock availability to the consumer behavior. The final report is updated to address the impact of COVID-19 on the Aquaculture Feed and Pharmaceuticals market.

Trusted Business Insights is tracking mining/oil and gas, transportation, employment services, travel arrangements, and the leisure and hospitality sector closely as they are likely to be the hardest-hit sectors. Utilities, local pharma, diagnostics, consumer goods and durables, agro chem and fertilizers, and telecommunications are the sectors that will be weathering the COVID-19 storm and most likely come out relatively unscathed. Interdependencies of sectors are factored in our research report on the Aquaculture Feed and Pharmaceuticals market."
Aquaculture refers to the breeding, harvesting of all kinds of freshwater and marine water species including fish, shellfish, and plants. It is mainly used for the commercial purpose in the food industry, pharmaceutical industry, nutritional and biotechnological industry. Aquaculture feed and pharmaceuticals is likely to be influenced by innovations and research in biologics and pharmaceuticals in the coming years.
The most prominent driver that has propelled the global market for aquaculture feed and pharmaceuticals is the growing demand for R&D in the field. This has further eased the entry of drugs, medicated feed, and vaccines in regional markets of developed nations like the United States of America and Canada. Owing to this, the aquaculture feed and pharmaceuticals industry has inorganically grown by liaising with key players. Moreover, if certain guidelines and compliance standards are met, there is no restriction on the use of extra-label drugs in the U.S., which could further fortify the market.
Measures to immune fishes against diseases is also a substantially effectual driver. Alongside this, aquaculture has become a vital source of food for human consumption, because of which various government initiatives are aiming to rid aqua life of the menace of diseases.

The global Aquaculture Feed and Pharmaceuticals market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Aquaculture Feed and Pharmaceuticals volume and value at global level, regional level and company level. From a global perspective, this report represents overall Aquaculture Feed and Pharmaceuticals market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
    Norel
    Bayer
    Growel Feeds
    Evonik
    Biomin Holding
    Novus International
    Aller Aqua
    Ridley Corporation
    Nutriad
    Cargill
    Beneo
    Alltech
    Skretting
    Growel Feeds
    Neovia Vietnam
    Zoetis

Segment by Regions
    North America
    Europe
    China
    Japan

Segment by Type
    Pharmaceutical
    Biologics
    Medicated Feed

Segment by Application
    Molluscs
    Shrimp
    Salmons
    Carps
    Tilapia
    Catfish
    Others